HTGMQ — HTG Molecular Diagnostics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for HTG Molecular Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.1	33	28.7	21.9	12.2
Net Total Accounts Receivable
Net Total Receivables	5.01	3.16	1.59	2.09	1.42
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	38	41.4	32.9	27.2	15.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.37	3.45	2.24	2.46	1.61
Other Long Term Assets
Total Assets	43.8	45.1	35.2	30.5	17.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.02	8.9	7.24	9.94	8.27
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.7	21.1	20.7	20.1	12.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	21.1	24	14.5	10.4	5.39
Total Liabilities & Shareholders' Equity	43.8	45.1	35.2	30.5	17.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding